ABVC BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Abvc Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2015 to Q3 2024.
  • Abvc Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 12.4M shares, a 206% increase year-over-year.
  • Abvc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.34M shares, a 36.9% increase from 2022.
  • Abvc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.17M shares, a 87.4% decline from 2021.
  • Abvc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 25.1M shares, a 27.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 12.4M +8.35M +206% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 11.3M +8.01M +242% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 9.74M +6.43M +194% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q4 2023 4.34M +1.17M +36.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 4.06M +797K +24.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 3.31M +178K +5.69% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 3.31M -26.4M -88.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q4 2022 3.17M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 3.26M -23.6M -87.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 3.13M -21.3M -87.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 29.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 26.9M +7.39M +37.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 24.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q3 2020 19.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2019 17.4M +5.81M +50.1% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 15M +3.37M +29% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-28
Q4 2018 214M +137K +0.06% Oct 1, 2018 Dec 31, 2018 10-K 2019-04-15
Q3 2018 214M +180K +0.08% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q2 2018 11.6M -202M -94.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 11.6M -200M -94.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28
Q4 2017 214M +2.93M +1.39% Oct 1, 2017 Dec 31, 2017 10-KT 2018-04-13
Q3 2017 214M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 214M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 212M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 211M +46.9M +28.6% Oct 1, 2016 Dec 31, 2016 10-Q/A 2018-03-19
Q4 2015 164M Oct 1, 2015 Dec 31, 2015 10-Q/A 2018-03-19
Q3 2015 161M Jul 21, 2015 Sep 30, 2015 10-K/A 2017-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.